EODData

FRA, NXOA: Nicox S.A

23 Dec 2025
LAST:

0.2430

CHANGE:
 0.01
OPEN:
0.2850
HIGH:
0.2850
ASK:
0.0000
VOLUME:
5.2K
CHG(%):
2.32
PREV:
0.2375
LOW:
0.2430
BID:
0.0000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
23 Dec 250.28500.28500.24300.24305.2K
22 Dec 250.28150.28150.23750.23755.2K
19 Dec 250.28600.28600.23400.23405.2K
18 Dec 250.28750.28750.23850.23855.2K
17 Dec 250.28750.28750.24000.24005.2K
16 Dec 250.29200.29200.24000.24005.2K
15 Dec 250.29050.29050.23950.23951.5K
12 Dec 250.29800.29800.24300.24301.5K
10 Dec 250.29250.29250.24400.24401.5K
09 Dec 250.29400.29400.24500.24501.5K

PROFILE

Name:Nicox S.A
About:Nicox S.A., together with its subsidiaries, operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. The company's lead product candidate is NCX 470, a novel nitric oxide (NO)-donating bimatoprost eye drop for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in Phase 3 clinical trial. It also develops NCX 4251, a novel patented ophthalmic suspension of fluticasone propionate nanocrystals that is in Phase 2b clinical trial for the treatment of dry eye disease; and NCX 1728, an NO-donating phosphodiesterase-5 inhibitor, which is in preclinical evaluation. In addition, the company offers VYZULTA, a latanoprostene bunod ophthalmic solution to treat patients with open-angle glaucoma or ocular hypertension; and ZERVIATE, a cetirizine ophthalmic solution for the treatment of ocular related associated with allergic conjunctivitis. Nicox S.A. was founded in 1996 and is headquartered in Biot, France.
Sector:Healthcare
Industry:Biotechnology
Address:Sundesk Sophia Antipolis, Biot, France, 06410
Website:https://www.nicox.com
ISIN:FR0013018124

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-0.69 
Forward P/E:5.54 
Price to Sales:6.84 
Price to Book:5.86 
Profit Margin:0.86 
Operating Margin:-3.38 
Return on Assets:-0.92 
Return on Equity:-6.56 
Revenue:3.32M 
Shares:72.2M 
Market Cap:17.54M 

TECHNICAL INDICATORS

MA5:0.241.8%
MA10:0.241.1%
MA20:0.252.4%
MA50:0.2814.2%
MA100:0.3128.9%
MA200:0.266.1%
STO9:14.06 
STO14:12.41 
RSI14:43.68
WPR14:-85.83 
MTM14:-0.01
ROC14:-0.03 
ATR:0.05 
Week High:0.2920.2%
Week Low:0.233.8%
Month High:0.3126.1%
Month Low:0.236.1%
Year High:0.70188.1%
Year Low:0.1648.2%
Volatility:168.50 

RECENT SPLITS

Date Ratio
03 Dec 20151-5
14 Jun 20023-1